Used in pharmaceutical synthesis as a key intermediate for developing kinase inhibitors, particularly in anticancer drug research. Its structure supports binding to enzyme active sites, enhancing selectivity and potency. Commonly employed in the preparation of targeted therapies for solid tumors. Also utilized in the development of fluorinated heterocyclic compounds to improve metabolic stability and bioavailability in drug candidates.